Nūmi is the first European biotech startup developing a breakthrough technology for the production of human breast milk ex vivo and its constituents using cell culture. This approach is based on cultivating human mammary cells under optimal conditions to ensure the secretion of essential breast milk components. Nūmi's mission is to transform the infant formula industry, providing infants with optimal nutrition when breastfeeding is not possible, desired, or sustained over time.